Displaying 81 - 100 of 168
FTC Announces Crackdown on Deceptively Marketed CBD Products
FTC Issues Consumer Tips for Avoiding COVID-19 Vaccine Scams
FTC Returns Almost $775,000 to Consumers Who Purchased Deceptively Advertised Arthritis and Joint Pain Relief Supplement Synovia from A.S. Research, LLC
A.S. Research, LLC (Synovia)
The marketers of a dietary supplement called Synovia agreed to settle FTC charges by halting the deceptive tactics they allegedly used to mislead consumers into thinking Synovia could treat arthritis and alleviate joint pain. In December 2020, the Commission announced it was returning almost $775,000 to consumers who both the deceptively marketed product.
Agency Information Collection Activities; Proposals, Submissions, and Approvals (Tobacco Reports)
FTC Refunds More Than $110,000 to Consumers Who Bought StimTein Joint Pain Relief Pills
FTC Refunds Almost $3.9 Million to Purchasers of Deceptively Advertised Quell Wearable Pain-Relief Device
FTC and State of Wisconsin Warn Hearing Aid Sellers About Deceptive Stimulus Payment Claims
Zaappaaz LLC
The Federal Trade Commission filed suit against Zaappaaz, the operators of wrist-band.com and other online storefronts, for failing to deliver on promises that they could quickly ship products like face masks, sanitizer, and other personal protective equipment (PPE) related to the coronavirus pandemic.
The lawsuit alleges that the company violated the FTC’s Mail, Internet and Telephone Order Rule (Mail Order Rule), which requires that companies notify consumers of shipping delays in a timely manner and give consumers the chance to cancel orders and receive prompt refunds.
FTC Order Stops the Marketer of “Thrive” Supplement from Making Baseless Claims It Can Treat, Prevent, or Reduce the Risks from COVID-19
FTC Sending Refund Checks Totaling Almost $149,000 to Consumers Who Bought ReJuvenation “Anti-Aging” Pill
FTC Sending Refund Checks Totaling More Than $470,000 to Consumers Defrauded by Misleading Health Claims for TrueAloe and AloeCran Supplements
FTC Sends Letters Warning 50 More Marketers to Stop Making Unsupported Claims That Their Products and Therapies Can Effectively Prevent or Treat COVID-19
FTC Alerts Consumers About Nursing Homes and Assisted Living Facilities Taking Stimulus Checks From Medicaid Patients
“Thrive” Supplement Marketer Agrees to Preliminary Order Barring Him from Claiming It Can Treat, Prevent, or Reduce the Risks Associated with COVID-19
Health Center, Inc. Settles FTC Allegations That It Targeted Older Consumers With Deceptive Claims for Health and Wellness Products
Tea Marketer Misled Consumers, Didn’t Adequately Disclose Payments to Well-Known Influencers, FTC Alleges
Statement of the Commission in the Matter of Teami, LLC
Displaying 81 - 100 of 168